Cargando…
Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice
Autores principales: | Fouquet, G., Franchi, P., Mittaine-Marzac, B., Laporte, N., Ihaddadene, H., Decroocq, J., Breal, C., Bouscary, D., Ammar, F., Zogo, A., Burgun, S., Zerbit, J., Willems, L., Deau-Fischer, B., Vignon, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164914/ https://www.ncbi.nlm.nih.gov/pubmed/34056680 http://dx.doi.org/10.1007/s00520-021-06297-4 |
Ejemplares similares
-
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era
por: Zerbit, Jeremie, et al.
Publicado: (2022) -
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
por: Henriquez, Soledad, et al.
Publicado: (2022) -
Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy
por: Fouquet, Guillemette, et al.
Publicado: (2021) -
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
por: Vazquez, Romain, et al.
Publicado: (2021) -
Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
por: Johnson, Natacha, et al.
Publicado: (2023)